ScottsMiracle-Gro Announces Strong Fourth Quarter Results; U.S. Consumer and Hawthorne Segments Exceed Expectations
U.S. Consumer segment sales increase 8% for full year, up 4% in Q4.
Read More
Category: US Stocks
Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
The third quarter of 2019 was a remarkable period of progress and execution for Zynerba.
Read More
HEXO Corp announces filing of annual report on form 40-F
The 2019 Annual Report contains HEXO’s 2019 annual information form and its audited financial...
Read More
The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment
The Company Board of Directors has approved the payment of a cash dividend of $0.58 per share.
Read More
Cara Therapeutics Reports Third Quarter 2019 Financial Results
The company completed several key clinical, financing and licensing objectives that position the Company well during the quarter.
Read MoreGET LISTED
